The Noninvasive Blood Pressure Measurement Effect on the Hypotension
The Effect of More Frequent Noninvasive Blood Pressure Measurement on the Detection of Intraoperative Hypotension
1 other identifier
interventional
640
1 country
1
Brief Summary
Around 300 million surgical operations are performed globally, and of these, 40 to 50 million are performed in the USA. The perioperative period is characterized by hemodynamic instability and, most importantly, hypotension. Intraoperative hypotension is frequent, and the incidence ranges between 5% and 99% during non-cardiac surgery, depending on the definition. The aim of the study is determined as the relationship between two different time intervals of measurements and time spent hypotensive under harm thresholds in non-cardiac surgery in adults having non-cardiac surgery. Secondarily, it will be determined if more frequent non-invasive blood pressure measurement use decreases postoperative acute kidney injury. Exploratory, it will be evaluated if more frequent non-invasive blood pressure use causes pain or nerve injury in the arms or not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2023
CompletedFirst Posted
Study publicly available on registry
August 15, 2023
CompletedStudy Start
First participant enrolled
October 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2026
December 29, 2025
December 1, 2025
2.1 years
July 27, 2023
December 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The time-average spend hypotensive (under MAP thresholds of 65 mmHg) for at least 1 minute
For the primary outcome, clinically important difference will be the time-average spend hypotensive (under MAP thresholds of 65 mmHg) for at least 1 minute since it has been shown clinically important in previous studies . We will assess this primary outcome in adults having non-cardiac surgery, a 2.5-minute interval of intraoperative blood measurement group compared to the standard 5-minute interval group.
Every 2.5 minute in the surgery upto end of the surgery.
Secondary Outcomes (1)
the time-average spend hypotensive (under MAP thresholds of <60, <50, and <40 mmHg [mmHg]) for at least 1 minute.
Every 2.5 minute in the surgery upto end of the surgery.
Other Outcomes (1)
Postoperative complications after surgery including acute myocardial infarction, acute kidney injury, non-fatal cardiac arrest, peripheral nerve injuries, arm pain and death and delrium status.
Postoperative time until 24th hours.
Study Arms (2)
5 min. BP
ACTIVE COMPARATORClinicians will carry out randomized treatments in coordination with research staff. The treatments will be: 1) Ephedrine treatment to maintain intraoperative MAP ≥60 mmHg, delayed resumption of chronic antihypertensive medications as monitoring with 5 min. Blood pressure management. The staff anesthesiologist will administer an ephedrine sulfate injection. An initial dose of 5 to 10 mg given as an intravenous bolus is advised for the treatment of clinically significant hypotension during anesthesia to provide an increase in blood pressure in case of MAP\< 60 mmHg. However, the dose of each will be titrated as necessary to reach the target mean arterial pressures.
2.5 min. BP
ACTIVE COMPARATORClinicians will carry out randomized treatments in coordination with research staff. The treatments will be: 2) Ephedrine treatment to maintain intraoperative MAP ≥60 mmHg, delayed resumption of chronic antihypertensive medications as monitoring with 2.5 min. Blood pressure management. The staff anesthesiologist will administer an ephedrine sulfate injection. An initial dose of 5 to 10 mg given as an intravenous bolus is advised for the treatment of clinically significant hypotension during anesthesia to provide an increase in blood pressure in case of MAP\< 60 mmHg. However, the dose of each will be titrated as necessary to reach the target mean arterial pressures.
Interventions
NIBP measurements will be recorded intraoperatively every 2.5 minutes for the group of 2.5 min. Blood pressure management or every 5 minutes for the other group of 5 min. Blood pressure management after providing randomization before the surgery. A calibrated and time-matched same type of standard anesthetic monitor will be used. The monitor will measure blood pressure and display the mean, systolic and diastolic values. All blood pressure measurements will be discontinued before the PACU transfer. Data will be automatically downloaded from the monitor to a computer using a software interface program.
Eligibility Criteria
You may qualify if:
- Age \> 18 years;
- ASA Physical Status 1 and 3;
- Non-cardiac surgery with expected surgery duration ≥ 2 hours;
- Supine position during the surgery;
- Regional or general anesthesia;
- Planned hospital stay time of at least 24 hours.
You may not qualify if:
- Patients who confirm to be pregnant and/or nursing mothers;
- Patients with an intra-aortic balloon pump (IABP) or ventricular assist device(s);
- Has a condition that precludes routine or tight blood pressure management;
- Mean arterial blood pressure differences between right and left arm ≥ 5 mmHg;
- Patient who has physically disabled their arms:
- \. Emergency surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Konya City Hospitallead
- The Cleveland Cliniccollaborator
- Bakirkoy Dr. Sadi Konuk Research and Training Hospitalcollaborator
Study Sites (1)
Konya City Hospital
Konya, Meram, 42140, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yasin Tire, Assoc. Prof.
Konya City Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr. Yasin Tire
Study Record Dates
First Submitted
July 27, 2023
First Posted
August 15, 2023
Study Start
October 25, 2024
Primary Completion (Estimated)
November 25, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
December 29, 2025
Record last verified: 2025-12